Case Study: Biopharmaceutical Company achieves faster rare disease diagnosis and launch readiness with Veeva Systems

Data and Platform Needs to Prepare for a Rare Disease Launch

A biopharmaceutical company preparing for its first rare disease launch faced major challenges finding patients in a condition that is often misdiagnosed, understanding a long and complex patient journey, and gaining visibility into specialty pharmacy prescribing. The company turned to Veeva Systems and its Veeva Longitudinal Patient Data to analyze patient journeys and identify key specialists, referral patterns, and disease markers.

Veeva Systems helped the customer use five years of longitudinal data to uncover meaningful comorbidities, segment high-risk HCPs, and better target outreach to doctors treating potential patients. The result was improved predictive modeling, earlier intervention and diagnosis opportunities, clearer treatment-team visibility, and a stronger pre-launch foundation with defined launch KPIs.